Noninfectious uveitis: strategies to optimize treatment compliance and adherence

被引：12

作者：

Dolz-Marco, Rosa ^{[1
]}

Gallego-Pinazo, Roberto ^{[1
]}

Diaz-Llopis, Manuel ^{[2
]}

Cunningham, Emmett T., Jr. ^{[3
,4
,5
,6
]}

Arevalo, J. Fernando ^{[7
,8
]}

机构：

[1] Univ & Polytech Hosp La Fe, Dept Ophthalmol, Unit Macula, Valencia, Spain

[2] Univ Valencia, Fac Med, E-46003 Valencia, Spain

[3] Calif Pacific Med Ctr, Dept Ophthalmol, San Francisco, CA USA

[4] Stanford Univ, Dept Ophthalmol, Sch Med, Stanford, CA 94305 USA

[5] Univ Calif San Francisco, Francis I Proctor Fdn, Med Ctr, San Francisco, CA 94143 USA

[6] West Coast Retina Med Grp, San Francisco, CA USA

[7] King Khalid Eye Specialist Hosp, Vitreoretina Div, Riyadh, Saudi Arabia

[8] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Retina Div, Baltimore, MD 21287 USA

来源：

CLINICAL OPHTHALMOLOGY | 2015年 / 9卷

关键词：

noninfectious uveitis; intraocular inflammation; immunosuppressive treatment; adherence; compliance; therapeutic failure;

D O I：

10.2147/OPTH.S36650

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Noninfectious uveitis includes a heterogenous group of sight-threatening ocular and systemic disorders. Significant progress has been made in the treatment of noninfectious uveitis in recent years, particularly with regard to the effective use of corticosteroids and non-corticosteroid immunosuppressive drugs, including biologic agents. All of these therapeutic approaches are limited, however, by any given patient's ability to comply with and adhere to their prescribed treatment. In fact, compliance and adherence are among the most important patient-related determinants of treatment success. We discuss strategies to optimize compliance and adherence.

引用

页码：1477 / 1481

页数：5

共 38 条

[1] Cytokines and Biologics in non-infectious autoimmune uveitis: Bench to Bedside
Agrawal, Rupesh
Iyer, Jayant
Connolly, John
Iwata, Daiju
Teoh, Stephen
[J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2014, 62 (01) : 74 - 81
[2] [Anonymous], 2015, PLANT
[3] Compliance, concordance, adherence
Aronson, Jeffrey K.
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (04) : 383 - 384
[4] Atreja Ashish, 2005, MedGenMed, V7, P4
[5] A Clinician's Guide to the Assessment and Management of Nonadherence in Glaucoma
Budenz, Donald L.
[J]. OPHTHALMOLOGY, 2009, 116 (11) : S43 - S47
[6] 'Steroid treatment card' compliance is suboptimal but can be improved
Burgess, P.
O'Dowd, J.
Kumar, N.
[J]. EYE, 2010, 24 (08) : 1409 - 1410
[7] Centers for Disease Control and Prevention, CDC CLEAR COMM IND
[8] Exogenous factors influencing endogenous inflammation: what can patients do to improve control of their own uveitis?
Cunningham, Emmett T., Jr.
[J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (07) : 813 - 814
[9] Intravitreal steroids for macular edema: The past, the present, and the future
Cunningham, Matthew A.
Edelman, Jeffrey L.
Kaushal, Shalesh
[J]. SURVEY OF OPHTHALMOLOGY, 2008, 53 (02) : 139 - 149
[10] Smartphone medication adherence apps: Potential benefits to patients and providers
Dayer, Lindsey
Heldenbrand, Seth
Anderson, Paul
Gubbins, Paul O.
Martin, Bradley C.
[J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2013, 53 (02) : 172 - 181

← 1 2 3 4 →